CA Patent

CA2880083A1 — Deuterated baricitinib

Assigned to Concert Pharmaceuticals Inc · Expires 2014-02-20 · 12y expired

What this patent protects

The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.

USPTO Abstract

The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.

Drugs covered by this patent

Patent Metadata

Patent number
CA2880083A1
Jurisdiction
CA
Classification
—
Expires
2014-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Concert Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.